Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    ENDRA Life Sciences Inc.

    NASDAQ: NDRA · Real-Time Price · USD
    3.28
    -0.11 (-3.24%)
    At close: Jun 17, 2025, 3:59 PM
    3.40
    3.66%
    After-hours: Jun 17, 2025, 06:45 PM EDT

    ENDRA Life Sciences Statistics

    Share Statistics

    ENDRA Life Sciences has 738.37K shares outstanding. The number of shares has increased by -73.65% in one year.

    Shares Outstanding

    n/a
    		 738.37K

    Shares Change (YoY)

    n/a
    		 -73.65%

    Shares Change (QoQ)

    n/a
    		 0%

    Owned by Institutions (%)

    n/a
    		 0.01%

    Shares Floating

    n/a
    		 738.25K

    Failed to Deliver (FTD) Shares

    n/a
    		 450

    FTD / Avg. Volume

    n/a
    		 0.26%

    Short Selling Information

    The latest short interest is 51.41K, so 6.96% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 51.41K

    Short % of Shares Out

    n/a
    		 6.96%

    Short % of Float

    n/a
    		 6.96%

    Short Ratio (days to cover)

    n/a
    		 1.4

    Valuation Ratios

    The PE ratio is -0.11 and the forward PE ratio is -0.34. ENDRA Life Sciences's PEG ratio is 0.

    PE Ratio

    n/a
    		 -0.11

    Forward PE

    n/a
    		 -0.34

    PS Ratio

    n/a
    		 0

    Forward PS

    n/a
    		 8.1

    PB Ratio

    n/a
    		 0.49

    P/FCF Ratio

    n/a
    		 -0.17

    PEG Ratio

    n/a
    		 0
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for ENDRA Life Sciences.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 5.67, with a Debt / Equity ratio of 0.23.

    Current Ratio

    n/a
    		 5.67

    Quick Ratio

    n/a
    		 5.67

    Debt / Equity

    n/a
    		 0.23

    Debt / EBITDA

    n/a
    		 -0.05

    Debt / FCF

    n/a
    		 -0.08

    Interest Coverage

    n/a
    		 0

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 n/a

    Profits Per Employee

    n/a
    		 $-547,997.48

    Employee Count

    n/a
    		 21

    Asset Turnover

    n/a
    		 0

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 n/a

    Effective Tax Rate

    n/a
    		 0%

    Stock Price Statistics

    The stock price has increased by -98.56% in the last 52 weeks. The beta is -0.22, so ENDRA Life Sciences's price volatility has been lower than the market average.

    Beta

    n/a
    		 -0.22

    52-Week Price Change

    n/a
    		 -98.56%

    50-Day Moving Average

    n/a
    		 3.92

    200-Day Moving Average

    n/a
    		 5.64

    Relative Strength Index (RSI)

    n/a
    		 44.42

    Average Volume (20 Days)

    n/a
    		 173,463

    Income Statement

    Revenue

    n/a
    		 n/a

    Gross Profit

    n/a
    		 n/a

    Operating Income

    n/a
    		 -18.14M

    Net Income

    n/a
    		 -11.51M

    EBITDA

    n/a
    		 -11.3M

    EBIT

    n/a
    		 n/a

    Earnings Per Share (EPS)

    n/a
    		 -56.94
    Full Income Statement

    Balance Sheet

    The company has 3.23M in cash and 584.42K in debt, giving a net cash position of 2.65M.

    Cash & Cash Equivalents

    n/a
    		 3.23M

    Total Debt

    n/a
    		 584.42K

    Net Cash

    n/a
    		 2.65M

    Retained Earnings

    n/a
    		 -103.44M

    Total Assets

    n/a
    		 3.17M

    Working Capital

    n/a
    		 1.61M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -7.4M and capital expenditures -16K, giving a free cash flow of -7.42M.

    Operating Cash Flow

    n/a
    		 -7.4M

    Capital Expenditures

    n/a
    		 -16K

    Free Cash Flow

    n/a
    		 -7.42M

    FCF Per Share

    n/a
    		 -36.7
    Full Cash Flow Statement

    Margins

    Gross Margin

    n/a
    		 n/a

    Operating Margin

    n/a
    		 n/a

    Pretax Margin

    n/a
    		 n/a

    Profit Margin

    n/a
    		 n/a

    EBITDA Margin

    n/a
    		 n/a

    EBIT Margin

    n/a
    		 n/a

    FCF Margin

    n/a
    		 n/a

    Dividends & Yields

    NDRA does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    The average price target for NDRA is $46, which is 1302.4% higher than the current price. The consensus rating is "Buy".

    Price Target

    n/a
    		 $46

    Price Target Difference

    n/a
    		 1302.4%

    Analyst Consensus

    n/a
    		 Buy

    Analyst Count

    n/a
    		 1
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Stock Splits

    The last stock split was on Nov 7, 2024. It was a backward split with a ratio of 1:35.

    Last Split Date

    n/a
    		 Nov 7, 2024

    Split Type

    n/a
    		 backward

    Split Ratio

    n/a
    		 1:35

    Scores

    Altman Z-Score

    n/a
    		 -52.85

    Piotroski F-Score

    n/a
    		 4

    Add to Watchlist